AMFI - Registered Mutual Fund Distributor

Curis Lifesciences Limited IPO

Curis Lifesciences Limited IPO

₹ 256000 / 2000 Shares Shares
Minimum Investment

Curis Lifesciences Limited IPO

Issues Price

₹120-128 per equity share

Curis Lifesciences Limited IPO

Open Date

07 Nov 2025

Close Date

11 Nov 2025

Lot Size

1000

Min. Investment

₹ 256000

Issue Price

₹120-128

Listing Date

14 Nov 2025

Issues Size

21,50,000 shares(aggregating up to ₹27.52 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

2000 Shares

Offered To Public

2000 Shares

Curis Lifesciences Limited IPO

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.

Founded In

2020

Managing Director

Dharmesh Dasharathbhai Patel

Parent Organization

Curis Lifesciences Limited IPO

Application for Curis Lifesciences Limited IPO

Apply as Price Range Apply Upto
Individual (min) ₹120-128 ₹2,56,000
Individual(max) ₹120-128 ₹2,56,000
SHNI(min) ₹120-128 ₹3,84,000
SHNI(max) ₹120-128 ₹8,96,000
BHNI(min) ₹120-128 ₹10,24,000

Apply for all eligible candidates, Curis Lifesciences Limited IPO.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

5 Out of 5 (11778 Reviews)

KSquare delivers exceptional clarity in their NFO briefings. Their platform made participating easy, and I felt informed throughout the whole process.

Asmita Rao

Asmita Rao

Clinical Researcher

KSquare really simplified the NPS process for me. I appreciate their educational approach and helpful customer support.

Kavita Iyer

Kavita Iyer

Biology Lecturer

The automatic deductions and growth charts at KSquare keep me informed and on track. It’s great for anyone serious about long-term financial goals.

Kunal Mishra

Kunal Mishra

Project Manager

Quick approvals, low documentation, and expert help—KSquare’s loan service is ideal for anyone needing funds quickly.

Priyanka Seth

Priyanka Seth

Fashion Designer

Thanks to KSquare, I purchased my first car without loans. The SIP plan was perfectly calculated and aligned with my budget, making everything financially smooth and stress-free.

Harsh Mehta

Harsh Mehta

Thanks to KSquare, my retirement plan feels organized. Their NPS tools and knowledge gave me real confidence in the future.

Tanya Khosla

Tanya Khosla

PR Consultant

I recommend KSquare to anyone who’s unsure about mutual funds. Their platform is supportive, beginner-friendly, and offers great fund insights to plan ahead.

Shraddha Menon

Shraddha Menon

Education Consultant

Getting a loan against my mutual funds was hassle-free with KSquare. Very professional and transparent experience.

Rohit Verma

Rohit Verma

Marketing Consultant

I use KSquare to manage my NRI investments. They provide clarity, legal compliance, and reliable support every step of the way. Excellent platform!

Siddharth Jain

Siddharth Jain

Business Owner

I’m impressed by how easy KSquare made mutual fund investing. Their platform is clean, quick, and their support staff is always ready to help.

Reena Saxena

Reena Saxena

Art Teacher

FAQ's

Frequenlty Asked Question

What is the role of a fund manager in mutual funds?

Fund managers decide where to invest the pooled money, aiming to maximize returns based on the fund’s strategy.

What are mutual funds and how do they work?

Mutual funds pool money from many investors to invest in a diversified portfolio of stocks, bonds, or other assets managed by professionals.

What documents are needed to invest in an NFO through KSquare?

You’ll need KYC-compliant documents like PAN, Aadhaar, and bank details to invest in NFOs through KSquare.

Can I nominate someone for my NPS account?

Yes, nomination is mandatory and can be easily added or updated through your KSquare profile.

Is NPS better than PPF or EPF for retirement?

NPS can offer higher returns due to market exposure, while PPF and EPF are safer but lower-yielding. It’s best to diversify.

Can I start SIPs with a small monthly amount?

Yes, KSquare allows flexible SIP amounts, enabling anyone to start small and gradually increase investments based on comfort

Is it legal for NRIs to invest in Indian markets via KSquare?

Absolutely. KSquare complies with all SEBI and RBI guidelines, ensuring legal and secure investments for NRIs.

Is SIP a good option for first-time investors?

Absolutely! SIPs are ideal for beginners due to their simplicity, flexibility, and potential for long-term wealth creation.

App Store

Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.